Allergan

Allergan will not bid for Shire: Sources
Allergan will not bid for Shire: Sources
CNBC
Allergan
Shire
M&A
Takeda
Flag link:
A bidding war is brewing over $50 billion drugmaker Shire
A bidding war is brewing over $50 billion drugmaker Shire
Business Insider
Shire
Takeda
Allergan
M&A
Flag link:
Allergan Announces Launch of the TrueTear Intranasal Neurostimulation Device
Allergan Announces Launch of the TrueTear Intranasal Neurostimulation Device
CP Wire
Allergan
devices
TrueTear
dry eye disease
Flag link:
Allergan Announces Launch of the TrueTear Intranasal Neurostimulation Device
Allergan
dry eye disease
TrueTear
Flag link:
Allergan toys with $5B women's health sale to boost bottom-feeding shares
Allergan toys with $5B women's health sale to boost bottom-feeding shares
Fierce Pharma
Allergan
Women's Health
M&A
Flag link:
Results from Third of Three Pivotal Trials of Cariprazine in Bipolar I Depression Mostly Positive
Results from Third of Three Pivotal Trials of Cariprazine in Bipolar I Depression Mostly Positive
CP Wire
cariprazine
bipolar disorder
Allergan
Gedeon Richter
clinical trials
Flag link:
Results from Third of Three Pivotal Trials of Cariprazine in Bipolar I Depression Mostly Positive
Allergan
Geodon Richter
Vraylar
bipolar disorder
Flag link:
Drug companies want Supreme Court to take eye drop dispute
Drug companies want Supreme Court to take eye drop dispute
Yahoo/AP
eye drops
eye health
Supreme Court
Allergan
Bausch & Lomb
Merck
Pfizer
Flag link:
Allergan's much-maligned tribal licensing deal wins reprieve at appeals court
Allergan's much-maligned tribal licensing deal wins reprieve at appeals court
Fierce Pharma
Allergan
Restasis
patents
Flag link:
Doctors expect enthusiasm for Allergan's high-flying Zeltiq to fade: survey
Doctors expect enthusiasm for Allergan's high-flying Zeltiq to fade: survey
Fierce Pharma
Allergan
Zeltiq
physicians
Flag link:
Racing Allergan, Biohaven Touts Migraine Drug Data, But Shares Sink
Racing Allergan, Biohaven Touts Migraine Drug Data, But Shares Sink
Xconomy
Allergan
Biohaven Pharmaceuticals
migraines
rimegepant
Flag link:
Amgen and Allergan Hopeful that Herceptin Biosimilar Approval Will Be Around the Corner
Amgen and Allergan Hopeful that Herceptin Biosimilar Approval Will Be Around the Corner
Xtalks
Amgen
Allergan
Herceptin
biosimilars
ABP 980
CHMP
EMA
Roche
Flag link:
Allergan - Forest gender discrimination $4 million settlement final date approaching
Allergan - Forest gender discrimination $4 million settlement final date approaching
CP Wire
Allergan
Forest Labs
gender discrimination
Class Action Lawsuit
settlements
Flag link:
Allergan - Forest gender discrimination $4 million settlement final date approaching
Allergan
Forest Labs
gender discrimination
Class Action Lawsuit
settlements
Flag link:
Ocugen’s Dry Eye Disease Therapy Could Compete with Allergan and Shire
Ocugen’s Dry Eye Disease Therapy Could Compete with Allergan and Shire
Xtalks
Ocugen
dry eye disease
OCU310
Shire
Allergan
Restasis
Xiidra
Flag link:
Tribe looks to stop patent board’s review of Restasis IP
Tribe looks to stop patent board’s review of Restasis IP
Drug Delivery Business News
Allergan
Restasis
intellectual property
patents
Flag link:
Forget that 'no breakup' vow. Allergan's CEO now says a strategic review is happening
Forget that 'no breakup' vow. Allergan's CEO now says a strategic review is happening
Fierce Pharma
Allergan
Pharma CEOs
Brent Saunders
spinoffs
Flag link:
Lousy year for shareholders, but Allergan CEO Brent Saunders sprints past Gorsky, Gonzalez with $32M pay package
Lousy year for shareholders, but Allergan CEO Brent Saunders sprints past Gorsky, Gonzalez with $32M pay package
Endpoints
executive pay
Pharma CEOs
Allergan
Brent Saunders
Alex Gorsky
Richard Gonzalez
Flag link:
Senators heap abuse on Allergan’s attempt at an end run around patent reviews, offer bill to stop ‘sham’
Senators heap abuse on Allergan’s attempt at an end run around patent reviews, offer bill to stop ‘sham’
Endpoints
Senate
Allergan
patents
Restasis
inter partes review
Flag link:
U.S. judge says opioid settlement roadblocks may prompt trials
U.S. judge says opioid settlement roadblocks may prompt trials
Reuters
opioids
opioid crisis
JNJ
Purdue Pharma
Allergan
Endo International
Teva Pharmaceutical
Flag link:

Pages